Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · IEX Real-Time Price · USD
7.53
-0.40 (-5.04%)
At close: Apr 18, 2024, 4:00 PM
7.52
-0.01 (-0.13%)
After-hours: Apr 18, 2024, 7:31 PM EDT
Abeona Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Abeona Therapeutics stock have an average target of 29, with a low estimate of 20 and a high estimate of 38. The average target predicts an increase of 285.13% from the current stock price of 7.53.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 24, 2023.
Analyst Ratings
The average analyst rating for ABEO stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $38 | Buy | Reiterates | $38 | +404.65% | Aug 24, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $38 | Buy | Reiterates | $38 | +404.65% | Jul 13, 2023 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +165.60% | May 24, 2023 |
| SVB Leerink | SVB Leerink | Hold Maintains $5 → $6 | Hold | Maintains | $5 → $6 | -20.32% | Nov 14, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $22 → $40 | Buy | Maintains | $22 → $40 | +431.21% | Nov 8, 2022 |
Financial Forecast
Revenue This Year
18.21M
from 3.50M
Increased by 420.20%
Revenue Next Year
72.52M
from 18.21M
Increased by 298.32%
EPS This Year
-1.96
from -2.53
EPS Next Year
-1.12
from -1.96
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 20.7M | 97.8M | 214.0M | 381.1M | 426.3M |
| Avg | 18.2M | 72.5M | 148.5M | 251.4M | 295.0M |
| Low | 15.7M | 48.1M | 85.7M | 127.4M | 169.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 491.0% | 436.9% | 195.1% | 156.6% | 69.6% |
| Avg | 420.2% | 298.3% | 104.8% | 69.3% | 17.3% |
| Low | 348.0% | 164.3% | 18.1% | -14.2% | -32.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.95 | 0.24 | 3.34 | 8.55 | 7.61 |
| Avg | -1.96 | -1.12 | 0.86 | 8.30 | 7.40 |
| Low | -1.94 | -2.38 | -1.46 | 7.98 | 7.10 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 891.6% | -8.3% |
| Avg | - | - | - | 863.3% | -10.9% |
| Low | - | - | - | 825.5% | -14.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.